EP2240496A4 - Preparation of esomeprazole magnesium and hydrates thereof - Google Patents

Preparation of esomeprazole magnesium and hydrates thereof

Info

Publication number
EP2240496A4
EP2240496A4 EP09709236A EP09709236A EP2240496A4 EP 2240496 A4 EP2240496 A4 EP 2240496A4 EP 09709236 A EP09709236 A EP 09709236A EP 09709236 A EP09709236 A EP 09709236A EP 2240496 A4 EP2240496 A4 EP 2240496A4
Authority
EP
European Patent Office
Prior art keywords
hydrates
preparation
esomeprazole magnesium
esomeprazole
magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09709236A
Other languages
German (de)
French (fr)
Other versions
EP2240496A2 (en
Inventor
Vijaya Bhaskar Bolugoddu
Venkata Annapurna Sasikala Cheemalapati
Siva Prasad Reddy Seerapu
Ravi Ram Chandrasekhar Elati
Surya Narayana Devarakonda
Sesha Reddy Yerraguntla
Ujjwal Kedia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of EP2240496A2 publication Critical patent/EP2240496A2/en
Publication of EP2240496A4 publication Critical patent/EP2240496A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
EP09709236A 2008-02-01 2009-01-30 Preparation of esomeprazole magnesium and hydrates thereof Withdrawn EP2240496A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN285CH2008 2008-02-01
US5993708P 2008-06-09 2008-06-09
PCT/US2009/032600 WO2009099933A2 (en) 2008-02-01 2009-01-30 Preparation of esomeprazole magnesium and hydrates thereof

Publications (2)

Publication Number Publication Date
EP2240496A2 EP2240496A2 (en) 2010-10-20
EP2240496A4 true EP2240496A4 (en) 2011-05-11

Family

ID=40952636

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09709236A Withdrawn EP2240496A4 (en) 2008-02-01 2009-01-30 Preparation of esomeprazole magnesium and hydrates thereof

Country Status (2)

Country Link
EP (1) EP2240496A4 (en)
WO (1) WO2009099933A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102285970B (en) * 2011-09-21 2014-07-23 石药集团欧意药业有限公司 Esomeprazole compound, preparation method and pharmaceutical compoistion
CN103214458B (en) * 2012-01-19 2015-04-22 上海汇伦生命科技有限公司 Esomeprazole magnesium dihydrate preparation method
WO2013123033A1 (en) * 2012-02-14 2013-08-22 The Board Of Trustees Of The Leland Stanford Junior University Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof
CN104610227A (en) * 2015-01-08 2015-05-13 浙江亚太药业股份有限公司 High-pressure hydrothermal preparation method for esomeprazole magnesium polymorphic compound

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007031845A2 (en) * 2005-09-14 2007-03-22 Glenmark Pharmaceuticals Limited Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
WO2009047775A2 (en) * 2007-10-08 2009-04-16 Hetero Drugs Limited Polymorphs of esomeprazole salts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE510650C2 (en) * 1997-05-30 1999-06-14 Astra Ab New association
WO2004046134A2 (en) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
US20050267159A1 (en) * 2004-05-28 2005-12-01 Aaipharma, Inc. Magnesium complexes of S-omeprazole
WO2006001755A1 (en) * 2004-06-24 2006-01-05 Astrazeneca Ab A new esomeprazole sodium salt crystal modification

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007031845A2 (en) * 2005-09-14 2007-03-22 Glenmark Pharmaceuticals Limited Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
WO2009047775A2 (en) * 2007-10-08 2009-04-16 Hetero Drugs Limited Polymorphs of esomeprazole salts

Also Published As

Publication number Publication date
EP2240496A2 (en) 2010-10-20
WO2009099933A2 (en) 2009-08-13
WO2009099933A3 (en) 2009-10-15

Similar Documents

Publication Publication Date Title
IL272376A (en) Multicyclic compounds and methods of use thereof
HK1172896A1 (en) Compounds and methods of use
HK1161094A1 (en) Compounds and methods of use
EP2364161A4 (en) Compositions containing satiogens and methods of use
HK1172505A1 (en) Slow release magnesium composition and uses thereof
HRP20160902T1 (en) Compositions and methods of use of phorbolesters
SG10201405568UA (en) 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
EP2334185A4 (en) Compositions and methods of using (r)-pramipexole
PL2346327T3 (en) Biocidal compositions and methods of use
HK1149933A1 (en) Diazacarbazoles and methods of use
EP2231665A4 (en) Novel compositions and methods of use
EP2464227A4 (en) Compounds and methods of use thereof
EP2515647A4 (en) Pheromone compositions and methods of use
IL209548A0 (en) Diazacarbazoles and methods of use
IL207724A0 (en) Cns pharmaceutical compositions and methods of use
GB0812890D0 (en) Compositions and methods of making compositions
ZA201102518B (en) Modified release formulation and methods of use
IL207827A0 (en) Apoaequorin-containing compositions and methods of using same
EP2240496A4 (en) Preparation of esomeprazole magnesium and hydrates thereof
EP2274350A4 (en) Polystyrene compositions having improved mechanical properties and methods of using same
HK1166953A1 (en) Compositions and methods of use
EP2291347A4 (en) Manufacture and use of alkyl p-toluates
IL209545A0 (en) Substotited pyrroles and methods of use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100802

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

A4 Supplementary search report drawn up and despatched

Effective date: 20110412

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111110